Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
31 March-01 April, 2025
Plastics Recycling EUPlastics Recycling EU
Not Confirmed
Not Confirmed
01-02 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
31 March-01 April, 2025
Plastics Recycling EUPlastics Recycling EU
Industry Trade Show
Not Confirmed
01-02 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
08 Apr 2024
// Julie Steenhuysen REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/geneos-cancer-vaccine-shrinks-liver-tumors-small-trial-2024-04-07/
07 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/geneos-therapeutics-announces-positive-phase-12-data-for-gt-30-trial-of-personalized-therapeutic-cancer-vaccine-302109588.html
27 Sep 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/geneos-therapeutics-closes-its-series-a3-financing-with-investment-of-5-million-301941077.html
28 Jul 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/geneos-therapeutics-nominated-for-2023-prix-galien-usa-startup-award-301887990.html
12 Apr 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/geneos-therapeutics-secures-5-million-in-series-a3-financing-301795107.html
24 Mar 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/geneos-therapeutics-secures-17-million-in-series-a2-financing-to-advance-personalized-cancer-immunotherapy-platform-301509602.html
ABOUT THIS PAGE